Assenagon Asset Management S.A. Sells 341,360 Shares of Option Care Health, Inc. $OPCH

Assenagon Asset Management S.A. cut its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 53.7% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 294,398 shares of the company’s stock after selling 341,360 shares during the quarter. Assenagon Asset Management S.A. owned approximately 0.18% of Option Care Health worth $8,172,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Teton Advisors Inc. boosted its stake in shares of Option Care Health by 2.2% in the 2nd quarter. Teton Advisors Inc. now owns 17,368 shares of the company’s stock valued at $564,000 after purchasing an additional 368 shares in the last quarter. Assetmark Inc. boosted its position in Option Care Health by 1.6% in the second quarter. Assetmark Inc. now owns 26,690 shares of the company’s stock valued at $867,000 after buying an additional 416 shares in the last quarter. State of Wyoming grew its stake in shares of Option Care Health by 1.8% during the second quarter. State of Wyoming now owns 25,135 shares of the company’s stock worth $816,000 after buying an additional 436 shares during the last quarter. Sheets Smith Wealth Management grew its stake in shares of Option Care Health by 1.9% during the second quarter. Sheets Smith Wealth Management now owns 24,938 shares of the company’s stock worth $810,000 after buying an additional 457 shares during the last quarter. Finally, GAMMA Investing LLC increased its holdings in shares of Option Care Health by 24.1% during the third quarter. GAMMA Investing LLC now owns 3,093 shares of the company’s stock worth $86,000 after buying an additional 600 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Citigroup reissued an “outperform” rating on shares of Option Care Health in a report on Friday, October 31st. Morgan Stanley started coverage on Option Care Health in a research note on Friday, October 17th. They set an “overweight” rating and a $35.00 price target on the stock. Cowen assumed coverage on Option Care Health in a research note on Thursday, October 2nd. They issued a “hold” rating for the company. Bank of America raised their price objective on shares of Option Care Health from $32.00 to $35.00 and gave the company a “buy” rating in a report on Tuesday, December 9th. Finally, TD Cowen reduced their target price on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating on the stock in a report on Monday, November 3rd. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and an average price target of $36.27.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of the firm’s stock in a transaction on Monday, November 3rd. The stock was acquired at an average price of $25.98 per share, for a total transaction of $987,240.00. Following the purchase, the director owned 413,390 shares of the company’s stock, valued at $10,739,872.20. This trade represents a 10.12% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.64% of the company’s stock.

Option Care Health Stock Up 0.3%

Option Care Health stock opened at $32.51 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.56 and a debt-to-equity ratio of 0.85. The firm’s fifty day moving average is $29.32 and its 200 day moving average is $29.37. The company has a market capitalization of $5.16 billion, a PE ratio of 25.80, a PEG ratio of 2.19 and a beta of 0.80. Option Care Health, Inc. has a 12-month low of $22.45 and a 12-month high of $35.53.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.